FOLFIRINOX Shows Promise as Second-line Therapy for Advanced Biliary Tract Cancer (IMAGE)

Pusan National University

FOLFIRINOX Shows Promise as Second-line Therapy for Advanced Biliary Tract Cancer

Caption

Researchers determined FOLFIRINOX may extend survival in advanced biliary tract cancer as a second-line therapy with manageable toxicity

Credit

Professor Yun Hak Kim from Pusan National University

Usage Restrictions

Cannot be reused without permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.